This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
OTC
HealthdirectFree Australian health advice you can count on.
INN: ceftazidime;avibactam
Data updated: 2026-04-25
Available in:
🇨🇿🇬🇧🇵🇹🇷🇺🇸🇰
Form
—
Dosage
—
Route
—
Storage
—
About This Product
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Manufacturer
Pfizer Ireland Pharmaceuticals Unlimited Company
ATC Code
J01DD52
Source
EMA · EMEA/H/C/004027
(
ARTG
)
Zavicefta is indicated for the treatment of the following infections in adults (see sections 4.4 Special warnings and precautions for use and 5.1 Pharmacodynamic properties):, Complicated intra-abdominal infection (cIAI) in combination with metronidazole.
Complicated urinary tract infection (cUTI) including pyelonephritis., Hospital-acquired pneumonia (HAP) including ventilator associated pneumonia (VAP).,Zavicefta is indicated for the treatment of the following infections in infants and paediatric patients (greater than or equal to 3 months to < 18 years) (see sections 4.4 Special warnings and precautions for use and 5.1 Pharmacodynamic properties):, Complicated intra-abdominal infection (cIAI) in combination with metronidazole.
Complicated urinary tract infection (cUTI) including pyelonephritis.,Consideration should be given to official guidance on the appropriate use of antibacterial agents.,To reduce the development of drug-resistant bacteria and maintain the effectiveness of Zavicefta and other antibiotics, Zavicefta should be used in combination with an antibacterial agent(s) active against Gram-positive and/or anaerobic pathogens when these are known or suspected to be contributing to the infectious process.
